The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing

By T. Helsten, S. Elkin, Elisa Arthur, Brett N. Tomson, J. Carter, Razelle Kurzrock. Clinical Cancer Research, 2015

670 citations recorded by the source corpus.

Subfields: Molecular Biology, Rheumatology, Surgery

View Paper: https://www.semanticscholar.org/paper/d4b86049ae2e059eb761e804b87501c298f98b04

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Z. Du
2. Christine Lovly

In Rheumatology

1. Z. Du
2. Christine Lovly

Citations in the corpus

• Mechanisms of receptor tyrosine kinase activation in cancer (2018, positive): “cluding FGFR1 in lung and breast cancer [82, 83], FGFR3 in breast and bladder cancer [84, 85], ERBB4 in breast and gastric cancer [86, 87], FLT3 in colon cancer [88], KIT in melanoma and GIST [89, 90], and PDGFRA in GBM [91].”